By Harsha K Rajasimha – AI is heralding a new era in drug development, promising groundbreaking solutions to longstanding challenges. Traditional clinical trials are often plagued by manual processes, leading to prolonged timelines and soaring costs.
Read More
Join us on Wednesday, April 24th as we discuss navigating the future of AI and its influence on provider verification, credentialing, and enrollment. Don’t miss this online event, register today!
By Jitin Asnaani – The sheer amount of information generated in healthcare and the variability of sources increases the risk of duplicate, inaccurate, incomplete, or inconsistent identity data. This can result in numerous hurdles.
By Cindy Jordan – Last year, US Surgeon General Dr. Vivek Murthy identified loneliness as a significant public health issue, prompting a search for solutions that offer reliable, affordable, and scalable mental health care. There is growing pressure on an already-taxed domestic healthcare system to provide personalized and accessible mental health services to those in need…
By Dr. Nick van Terheyden aka Dr. Nick – Digital collections do not quite replace everything the same as AI does not replace everything. We still need the human touch and pattern matching and decision-making while differences remain important.
This month’s AI report includes news and updates from Profluent, Xsolis, Tempus, SnapCare, AxiomEHR, Ontrak Health, Together by Renee, DrFirst, Talkdesk, Andor Health, MedeAnalytics, & more!
By Stuart Long – Everyone knows someone affected by cardiac disease. Of course, we all recognize the risk factors: age, lifestyle, preexisting conditions… But a quick read through the AHA’s “Most Read Survivor Stories of 2023” tells a different story: that cardiac disease can strike swiftly and indiscriminately.
By Branden Neish – Now after the initial AI boom, both patients and providers are starting to expect the integration of AI into everyday practice workflows and are excited about the host of incredible benefits generative AI can bring to the industry.
By Frank A. Fornari PhD – While physical activity, physical therapy, and structured exercise have long been considered effective treatments for Parkinson’s disease, their efficacy has been difficult to scientifically establish due to the inability to measure changes.